Skip to content

Clinical trials

Pathologic Complete Response trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Country / region: Italy Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20132
20181
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Active, not recruiting2
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Celgene1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Lucia Del Mastro,MD1
Michele Cavo1
University of Padova1
Xenikos1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response9
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1
Fallopian Tube Neoplasms1
Hereditary Sensory and Autonomic Neuropathies1
Leukemia, Myeloid, Acute1
Lymphoma, Follicular1
Multiple Myeloma1
Neoplasms1
Ovarian Neoplasms1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.